
There's a new drug to prevent Covid-19, but there won't be nearly enough for Americans who are eligible
CNN
For Americans who suffer from weak immune systems, it felt like a miracle occurred on December 8. That day, the US Food and Drug Administration authorized a drug to help keep immune-compromised people from getting infected with the coronavirus.
But that joy quickly turned to despair as patients learned the government has only contracted for enough doses for less than one-tenth the number of people who are eligible for it.
The first batch of the drug, called Evusheld, shipped out on Monday, according to a spokesperson for the US Department of Health and Human Services. Dr. Camille Kotton, an infectious disease expert at Mass General Brigham, said her medical system expects to receive in this shipment only doses to treat fewer than 1% of its thousands of immune-compromised patients.

Defense Secretary Pete Hegseth risked compromising sensitive military information that could have endangered US troops through his use of Signal to discuss attack plans, a Pentagon watchdog said in an unclassified report released Thursday. It also details how Hegseth declined to cooperate with the probe.

Two top House lawmakers emerged divided along party lines after a private briefing with the military official who oversaw September’s attack on an alleged drug vessel that included a so-called double-tap strike that killed surviving crew members, with a top Democrat calling video of the incident that was shared as part of the briefing “one of the most troubling things” he has seen as a lawmaker.

Authorities in Colombia are dealing with increasingly sophisticated criminals, who use advanced tech to produce and conceal the drugs they hope to export around the world. But police and the military are fighting back, using AI to flag suspicious passengers, cargo and mail - alongside more conventional air and sea patrols. CNN’s Isa Soares gets an inside look at Bogotá’s war on drugs.










